Meilien Ho

Effects of Fostamatinib, an Oral Spleen Tyrosine Kinase Inhibitor, in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate: Results From a Phase III, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group Study

Michael E. Weinblatt, Mark C. Genovese, Meilien Ho et al. · Arthritis & Rheumatology · 2014 · 114 citations

Medicine, Pharmacology, Pharmacotherapy +14

OSKIRA-4: a phase IIb randomised, placebo-controlled study of the efficacy and safety of fostamatinib monotherapy

Peter C. Taylor, Mark C. Genovese, Mike Greenwood et al. · Annals of the Rheumatic Diseases · 2014 · 45 citations

Medicine, Pharmacology, Pharmacotherapy +15

Association of common variation in glutathione S‐transferase genes with premature development of cardiovascular disease in patients with systemic sclerosis

V R Young, Meilien Ho, Alex S. F. Doney et al. · Arthritis & Rheumatism · 2003 · 36 citations

Medicine, Genetics, Molecular Genetics +13

Quantitative power Doppler ultrasound measures of peripheral joint synovitis in poor prognosis early rheumatoid arthritis predict radiographic progression

Dee Sreerangaiah, Michael Grayer, Benjamin A. Fisher et al. · Lara D. Veeken · 2015 · 32 citations · Full text

Medicine, Orthopedic Surgery, Diagnostic Imaging +16

Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study

Dimitrios A. Pappas, Fredrik Nyberg, Joel M. Kremer et al. · Clinical Rheumatology · 2018 · 31 citations

Medicine, Cardiology, Internal Medicine +14